Hubschwerlen C - Search Results

1

Design, synthesis, and evaluation of 2 beta-alkenyl penam sulfone acids as inhibitors of beta-lactamases.

Richter HG, Angehrn P, Hubschwerlen C, Kania M, Page MG, Specklin JL, Winkler FK. Richter HG, et al. Among authors: hubschwerlen c. J Med Chem. 1996 Sep 13;39(19):3712-22. doi: 10.1021/jm9601967. J Med Chem. 1996. PMID: 8809160

2

Pyrimido[1,6-a]benzimidazoles: a new class of DNA gyrase inhibitors.

Hubschwerlen C, Pflieger P, Specklin JL, Gubernator K, Gmünder H, Angehrn P, Kompis I. Hubschwerlen C, et al. J Med Chem. 1992 Apr 17;35(8):1385-92. doi: 10.1021/jm00086a006. J Med Chem. 1992. PMID: 1315393

3

Orally active 2-(alkyloxycarbonyl)-2-alkylideneethyl esters of cephalosporins.

Hubschwerlen C, Charnas R, Angehrn P, Furlenmeier A, Graser T, Montavon M. Hubschwerlen C, et al. J Antibiot (Tokyo). 1992 Aug;45(8):1358-64. doi: 10.7164/antibiotics.45.1358. J Antibiot (Tokyo). 1992. PMID: 1399857 Free article.

4

Antibacterial properties of Ro 40-6890, a broad-spectrum cephalosporin, and its novel orally absorbable ester, Ro 41-3399.

Angehrn P, Hohl P, Hubschwerlen C, Page M, Then R. Angehrn P, et al. Among authors: hubschwerlen c. Antimicrob Agents Chemother. 1992 Dec;36(12):2825-34. doi: 10.1128/AAC.36.12.2825. Antimicrob Agents Chemother. 1992. PMID: 1482153 Free PMC article.

5

Refined crystal structure of beta-lactamase from Citrobacter freundii indicates a mechanism for beta-lactam hydrolysis.

Oefner C, D'Arcy A, Daly JJ, Gubernator K, Charnas RL, Heinze I, Hubschwerlen C, Winkler FK. Oefner C, et al. Among authors: hubschwerlen c. Nature. 1990 Jan 18;343(6255):284-8. doi: 10.1038/343284a0. Nature. 1990. PMID: 2300174

6

Synthesis and structure-activity relationship of (lactamylvinyl)cephalosporins exhibiting activity against staphylococci, pneumococci, and enterococci.

Heinze-Krauss I, Angehrn P, Guerry P, Hebeisen P, Hubschwerlen C, Kompis I, Page MG, Richter HG, Runtz V, Stalder H, Weiss U, Wei CC. Heinze-Krauss I, et al. Among authors: hubschwerlen c. J Med Chem. 1996 Apr 26;39(9):1864-71. doi: 10.1021/jm950886v. J Med Chem. 1996. PMID: 8627610

7

Structure-based design of beta-lactamase inhibitors. 1. Synthesis and evaluation of bridged monobactams.

Heinze-Krauss I, Angehrn P, Charnas RL, Gubernator K, Gutknecht EM, Hubschwerlen C, Kania M, Oefner C, Page MG, Sogabe S, Specklin JL, Winkler F. Heinze-Krauss I, et al. Among authors: hubschwerlen c. J Med Chem. 1998 Oct 8;41(21):3961-71. doi: 10.1021/jm980023c. J Med Chem. 1998. PMID: 9767633

8

Structure-based design of beta-lactamase inhibitors. 2. Synthesis and evaluation of bridged sulfactams and oxamazins.

Hubschwerlen C, Angehrn P, Gubernator K, Page MG, Specklin JL. Hubschwerlen C, et al. J Med Chem. 1998 Oct 8;41(21):3972-5. doi: 10.1021/jm9800245. J Med Chem. 1998. PMID: 9767634

9

Phenyl beta-methoxyacrylates: a new antimalarial pharmacophore.

Alzeer J, Chollet J, Heinze-Krauss I, Hubschwerlen C, Matile H, Ridley RG. Alzeer J, et al. Among authors: hubschwerlen c. J Med Chem. 2000 Feb 24;43(4):560-8. doi: 10.1021/jm990002y. J Med Chem. 2000. PMID: 10691682

10

Hydroxamic acid derivatives as potent peptide deformylase inhibitors and antibacterial agents.

Apfel C, Banner DW, Bur D, Dietz M, Hirata T, Hubschwerlen C, Locher H, Page MG, Pirson W, Rossé G, Specklin JL. Apfel C, et al. Among authors: hubschwerlen c. J Med Chem. 2000 Jun 15;43(12):2324-31. doi: 10.1021/jm000018k. J Med Chem. 2000. PMID: 10882358

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

29 results

Search Page

Filters